CervoMed Inc. Files 8-K on Financials
Ticker: CRVO · Form: 8-K · Filed: Mar 18, 2025 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, sec-filing
TL;DR
CervoMed filed an 8-K on financials, check it out.
AI Summary
CervoMed Inc. filed an 8-K on March 18, 2025, reporting on its results of operations and financial condition as of March 17, 2025. The filing includes financial statements and exhibits, but does not detail specific financial figures or operational outcomes within the provided text.
Why It Matters
This 8-K filing provides an update on CervoMed Inc.'s financial condition and operations, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting financial condition and operations, with no immediate negative or positive news indicated in the provided text.
Key Numbers
- 001-37942 — Commission File Number (Identifies the company's SEC filing series.)
- 30-0645032 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- 20 Park Plaza, Suite 424 (location) — Principal executive offices address
- Boston, Massachusetts (location) — Principal executive offices city and state
- 02116 (location) — Principal executive offices zip code
- Diffusion Pharmaceuticals Inc. (company) — Former company name
- RestorGenex Corp (company) — Former company name
- Stratus Media Group, Inc (company) — Former company name
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text indicates the filing is for 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but does not specify the actual financial figures or operational outcomes.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported is March 17, 2025.
What is CervoMed Inc.'s state of incorporation?
CervoMed Inc. is incorporated in Delaware.
What is the primary business classification for CervoMed Inc. according to its SIC code?
CervoMed Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Has CervoMed Inc. operated under any previous names?
Yes, CervoMed Inc. has operated under the former names Diffusion Pharmaceuticals Inc., RestorGenex Corp, and Stratus Media Group, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 18, 2025 regarding CervoMed Inc. (CRVO).